PD-1 Inhibition With Camrelizumab in Cervical Cancer: A Systematic Review and Meta-Analysis.
- DOI
- 10.1097/coc.0000000000001352
- Published
- 2026 Jul 21
- Container
- American journal of clinical oncology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/coc.0000000000001352,
title = {PD-1 Inhibition With Camrelizumab in Cervical Cancer: A Systematic Review and Meta-Analysis.},
author = {Musheer A and Mannan MS and Khan MW and Bhatti A and Basit T and Hafeez AS and Javed H and Muhammad S},
year = {2026},
journal = {American journal of clinical oncology},
doi = {10.1097/coc.0000000000001352},
url = {https://doi.org/10.1097/coc.0000000000001352}
}RIS
TY - JOUR TI - PD-1 Inhibition With Camrelizumab in Cervical Cancer: A Systematic Review and Meta-Analysis. AU - Musheer A AU - Mannan MS AU - Khan MW AU - Bhatti A AU - Basit T AU - Hafeez AS AU - Javed H AU - Muhammad S PY - 2026 JO - American journal of clinical oncology DO - 10.1097/coc.0000000000001352 UR - https://doi.org/10.1097/coc.0000000000001352 ER -
APA
A, M., MS, M., MW, K., A, B., T, B., AS, H., H, J., & S, M. (2026). PD-1 Inhibition With Camrelizumab in Cervical Cancer: A Systematic Review and Meta-Analysis.. American journal of clinical oncology. https://doi.org/10.1097/coc.0000000000001352
Source records
- pubmed · retrieved 2026-09-26T17:17:48.070Z
- europe-pmc · retrieved 2026-09-26T17:17:48.083Z